Science for a Better Tomorrow: Curious 2024 Insights
暫譯: 為更美好的明天而科學:2024年好奇洞察

Betz, Ulrich A. K.

  • 出版商: Springer
  • 出版日期: 2025-08-19
  • 售價: $8,570
  • 貴賓價: 9.5$8,142
  • 語言: 英文
  • 頁數: 290
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3031936221
  • ISBN-13: 9783031936227
  • 相關分類: AI Coding生物資訊 Bioinformatics
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book explores the intersection of biosciences, artificial intelligence (AI), and information technology (IT), highlighting their potential to drive innovation in biomedicine and health, particularly in the context of pandemic resiliency and human longevity. The book expands on the discussion held at the Curious2024 - Future Insight Conference, capturing the innovative spirit and collaborative ethos of the conference.

In this book, readers will find a diverse array of topics, including individualized medicine for cardiovascular disease, the sustainable transformation of chemical processes, and the future of drug discovery through an AI-driven lens. The book also investigates the role of synthetic biology in leveraging the ground truth of intelligence and explores the potential of developing conscious service robots.

Chapters written by keynote speakers from the Curious2024 - Future Insight Conference emphasize the importance of interdisciplinary and transdisciplinary dialogue for breakthrough innovation. These contributions also provide a comprehensive analysis of the challenges and opportunities that lie ahead, making this book an essential read for those interested in the future of science and technology.

By highlighting the crucial role of scientists in solving today's problems and enabling the dreams of a better tomorrow, the book appeals to a broad readership of researchers, scholars, and practitioners in biosciences, AI, and IT. It also serves as a valuable resource for early career researchers seeking mentorship and guidance.

商品描述(中文翻譯)

本書探討生物科學、人工智慧 (AI) 與資訊科技 (IT) 的交集,強調它們在生物醫學與健康領域推動創新的潛力,特別是在疫情韌性與人類長壽的背景下。本書擴展了在 Curious2024 - Future Insight Conference 上進行的討論,捕捉了會議的創新精神與合作精神。

在本書中,讀者將發現多樣的主題,包括針對心血管疾病的個性化醫療、化學過程的可持續轉型,以及透過 AI 驅動的視角探索藥物發現的未來。本書還探討了合成生物學在利用智慧的真實基礎方面的角色,並探索開發意識服務機器人的潛力。

由 Curious2024 - Future Insight Conference 的主題演講者撰寫的章節強調跨學科與跨領域對話對突破性創新的重要性。這些貢獻還提供了對未來挑戰與機會的全面分析,使本書成為對科學與技術未來感興趣的讀者必讀的作品。

本書突顯科學家在解決當今問題與實現更美好明天的夢想中所扮演的關鍵角色,吸引了廣泛的讀者群,包括生物科學、人工智慧與資訊科技的研究者、學者與實務工作者。它也為尋求指導與輔導的早期職業研究者提供了寶貴的資源。

作者簡介

Ulrich Betz is Senior Vice President Innovation at Merck and Chairman of the Board of Future Insight e.V.. He has been appointed by the Federal President of the Federal Republic of Germany as a member of the German Council of Science and Humanities (Wissenschaftsrat). He is also a member of the LOEWE scientific advisory board for Hessen as well as a member of the board of the German Chemical Society (GDCh). Ulrich is an accomplished R&D manager with >25 years of experience in the pharmaceutical and chemical industry and has worked at various scientific and managerial positions at Bayer and Merck. He received his PhD in functional genomics and immunology from the University of Cologne, Germany, worked for his diploma thesis at the Max Planck Institute for Immunology and studied biochemistry and physiological chemistry at the University of Tübingen, Germany. He is a co-inventor of the anti-viral drugs Letermovir (Prevymis) and Pritelivir and has won several innovation awards such as the German Industry Innovation Award and two International Business Awards (Stevie Gold Awards Executive of the Year - Pharmaceuticals and Innovator of the Year). Ulrich is author and co-author of >100 publications and patents (e.g. Cell, Nature Medicine, Nature Biotechnology, Cell Reports, books).

作者簡介(中文翻譯)

烏爾里希·貝茲是默克公司的創新高級副總裁及Future Insight e.V.的董事會主席。他被德國聯邦總統任命為德國科學與人文學術委員會(Wissenschaftsrat)成員。他同時也是黑森州LOEWE科學諮詢委員會的成員,以及德國化學學會(GDCh)董事會的成員。烏爾里希是一位擁有超過25年製藥和化學行業經驗的資深研發經理,曾在拜耳和默克擔任多個科學及管理職位。他在德國科隆大學獲得功能基因組學和免疫學的博士學位,並在馬克斯·普朗克免疫學研究所完成其學位論文,還在德國圖賓根大學學習生物化學和生理化學。他是抗病毒藥物Letermovir(Prevymis)和Pritelivir的共同發明人,並獲得多項創新獎項,如德國工業創新獎和兩項國際商業獎(Stevie金獎年度執行長 - 製藥業及年度創新者)。烏爾里希是超過100篇出版物和專利的作者和共同作者(例如《Cell》、《Nature Medicine》、《Nature Biotechnology》、《Cell Reports》及書籍)。